Importantly, PLK1 is a synthetic lethal target in cancer driven by mutant KRAS (Luo et al, 2009), although how PLK1 crosstalks with oncogenic KRAS signaling remains incompletely understood. The gene discussed is KRAS; the disease is cancer.